Article

OTC: overwhelming and total confusion?

During resident clinic recently, I met an elderly woman suffering from age-related macular degeneration (AMD). Upset with 20/300 vision in her left eye, she was desperate to maintain her right eye's 20/25 vision.

During resident clinic recently, I met an elderly woman suffering from age-related macular degeneration (AMD). Upset with 20/300 vision in her left eye, she was desperate to maintain her right eye's 20/25 vision.

After counseling her about the causes of AMD, I advised her to stop smoking ("I've been trying to quit for years, honey") and eat plenty of green, leafy vegetables. The conversation then turned to nutritional supplements, and I explained that a very specific combination of vitamins and other nutrients could help decrease the rate of AMD progression by 25%.

"That's right. But, that combination also increased the chances of lung cancer in smokers," I said. "So we can either take that risk, or use the supplements without beta-carotene. They probably won't work as well for your vision, but they'll be safer."

"How do I know which ones are without beta-carotene?" she asked.

"Check the label. All the information will be right there."

We set up a follow-up appointment for 3 months, and I moved on to the next patient.

A dose of reality

I stopped to look around for a moment, bewildered by the choices. My local store carried vitamins from Bausch & Lomb, Alcon Laboratories, and a generic brand, all with catchy names ("PreserVision," "Ocuvite," "I-Caps," etc.). In addition, some mentioned AREDS directly, while others said "based on AREDS," and still others listed the names of other vitamins contained inside.

Now I was curious-and feeling a new empathy for my patient. Thinking back to an AMD lecture 2 months prior, I struggled to remember the exact nutrients that were studied in AREDS. Wasn't it vitamin A, C, and E, along with zinc and copper? But what about lutein and zeaxanthin-they are featured prominently on several of the boxes, but were they studied in AREDS? And how much of each nutrient was studied? I could only recall that it was high doses of each.

Related Videos
John Saharek, president of ImprimisRX, speaks with Ophthalmology Times' David Hutton on three new products the company will be featuring during the American Academy of Ophthalmology's 2021 annual meeting
What keeps you up at night in ophthalmology: Part II
Chris Adams, Diopter Corp CEO
Ramin Valian, of Allergan, discusses pharmaceuticals in the glaucoma industry at Glaucoma 360
© 2024 MJH Life Sciences

All rights reserved.